Exelixis (EXEL) Hmangaihna Thlan
Thlanh chiah a ngai$58.18Updated 25 Sep 2026 19:59 UTC
Change+0.41%
AI forecast: EXEL
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Lai a ngaih a hnu a 6 thlang
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Ri hlaam thlan a nih hi
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumHmi hnuai thawn
Exelixis, Inc. is a biotechnology company specializing in the development of promising small-molecule drugs for the treatment of cancer and other serious diseases, including kidney disease, thyroid cancer, and advanced melanoma. The company also establishes strategic partnerships with other pharmaceutical and biotechnology firms.
